Exane Derivatives’s Vinco Ventures, Inc. Common Stock BBIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,958
Closed -$85.2K 1053
2022
Q1
$85.2K Buy
+1,958
New +$78.1K 0.02% 490

Other funds holding BBIG

Exane Derivatives's BBIG Position: Q2 2022 in Review

Exane Derivatives sold out of Vinco Ventures, Inc. Common Stock (BBIG) in Q2 2022, closing a stake of 1,958 shares — an estimated $85.2K sold.

Exane Derivatives first reported a position in BBIG in Q1 2022 and held it in 1 quarter. The position peaked at $85.2K in Q1 2022. 88 funds tracked by Wall St. Rank hold BBIG as of Q2 2022.

  • Exane Derivatives reported no remaining Vinco Ventures, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,958 Vinco Ventures, Inc. Common Stock shares in Q2 2022, an estimated $85.2K.
  • Exane Derivatives first reported a position in Vinco Ventures, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Exane Derivatives's Vinco Ventures, Inc. Common Stock position peaked at $85.2K in Q1 2022.
  • 88 funds tracked by Wall St. Rank held Vinco Ventures, Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.